All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - Hemostasis
D3 - Session 3 - Analytical Aspects of D-Dimer Assays
Read more...
D3 - Session 2 - General Overview of Fibrinolysis
Read more...
D3 - Session 1 - Covid19 Associated Coagulopathies: A Year in Review
Read more...
Meet the Hemostasis Expert - Q&A - COVID19 and Hemostasis - Kuwait
Read more...
Covid19 Associated Coagulopathies: A Year in Review
Read more...
How do we manage cardiopulmonary bypass coagulopathy?
Read more...
Using heparin molecules to manage COVID-2019
Read more...
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Read more...
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
Early coagulation tests predict risk stratification and prognosis of COVID-19
Read more...
COVID-19 Related Coagulopathy: A Distinct Entity?
Read more...
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure
Read more...
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
Read more...
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
Read more...
The compelling arguments for the need of microvascular investigation in COVID-19 critical patients
Read more...
The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19
Read more...
Fibrinolysis and COVID‐19: A plasmin paradox
Read more...
Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications
Read more...
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Read more...
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink
Read more...
Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill
Read more...
Coagulopathy in COVID-19: Posted april 24, 2020
Read more...
Heparin - An old drug with multiple potential targets in Covid-19 therapy
Read more...
D-dimer Triage for COVID-19
Read more...
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Read more...
Dynamic relationship between D-dimer and COVID-19 severity
Read more...
Coagulation abnormalities and thrombosis in patients with COVID-19
Read more...
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Read more...
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
Read more...
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Potential role of platelets in COVID-19: Implications for thrombosis
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Curative anticoagulation prevents endothelial lesion in COVID-19 patients
Read more...
Fibrinolysis and COVID-19: A tale of two sites?
Read more...
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic
Read more...
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Read more...
Hemostatic alterations in COVID-19
Read more...
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Read more...
Coagulopathy in COVID-19
Read more...
High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?
Read more...
Coagulopathy of Coronavirus Disease 2019
Read more...
The unique characteristics of COVID-19 coagulopathy
Read more...
Re The source of elevated plasma D-dimer levels in COVID-19 infection
Read more...
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence
Read more...
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2
Read more...
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Read more...
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome
Read more...
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19
Read more...
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Read more...
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Read more...
Viscoelastic testing in COVID-19: a possible screening tool for severe disease?
Read more...
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome
Read more...
Frequency of lupus anticoagulant in COVID-19 patients
Read more...
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis
Read more...
Lupus anticoagulant is frequent in patients with Covid-19
Read more...
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Read more...
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Read more...
Clinical Characteristics of Coronavirus Disease 2019 in China
Read more...
Increased sFLT-1/PlGF ratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction
Read more...
Essential Role of Patient Blood Management in a Pandemic: A Call for Action
Read more...
Current Perspectives of Anticoagulation in Patients With COVID-19
Read more...
COVID-19 Related Arterial Coagulopathy
Read more...
COVID-19 and HELLP: Overlapping Clinical Pictures in Two Gravid Patients
Read more...
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation
Read more...
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
Read more...
Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring
Read more...
Macrothrombosis and stroke in patients with mild Covid‐19 infection
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
Read more...
Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
Read more...
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Read more...
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom
Read more...
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Read more...
Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female
Read more...
The vascular side of COVID-19 disease. Position paper of the International Union of Angiology
Read more...
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Read more...
https://pubmed.ncbi.nlm.nih.gov/32339221/
Read more...
Hematological findings and complications of COVID-19
Read more...
Coagulopathy of COVID-19 and antiphospholipid antibodies
Read more...
The versatile heparin in COVID-19
Read more...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Read more...
Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients
Read more...
A proposal for staging COVID-19 coagulopathy
Read more...
COVID-19-associated coagulopathy: An exploration of mechanisms
Read more...
Understanding the COVID-19 coagulopathy spectrum
Read more...
The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states
Read more...
Emergence of institutional antithrombotic protocols for coronavirus 2019
Read more...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Read more...
COVID‐19: A collision of complement, coagulation and inflammatory pathways
Read more...
Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients
Read more...
COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
Read more...
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)
Read more...
Dramatic presentation of acquired thombotic thrombocytopenic purpura associated with COVID-19
Read more...
D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
Read more...
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Read more...
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Read more...
Start
Prev
1
2
3
4
Next
End
Page 2 of 4
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection